DE VITA, Ferdinando
 Distribuzione geografica
Continente #
EU - Europa 167
AS - Asia 39
NA - Nord America 31
AF - Africa 2
SA - Sud America 1
Totale 240
Nazione #
IT - Italia 108
US - Stati Uniti d'America 31
IE - Irlanda 30
VN - Vietnam 24
FR - Francia 9
CN - Cina 6
SE - Svezia 6
NL - Olanda 5
DE - Germania 3
IN - India 3
KR - Corea 2
RU - Federazione Russa 2
UA - Ucraina 2
CZ - Repubblica Ceca 1
IL - Israele 1
LK - Sri Lanka 1
MA - Marocco 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
PE - Perù 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 240
Città #
Naples 51
Dublin 30
Dong Ket 24
Caserta 20
Stockholm 6
Ashburn 4
Houston 4
Marano Di Napoli 4
Wuhan 4
Clarks Summit 3
Florence 3
Milan 3
Bremen 2
Columbus 2
Council Bluffs 2
New York 2
San Vitaliano 2
Amsterdam 1
Andover 1
Ann Arbor 1
Aversa 1
Avezzano 1
Beijing 1
Bengaluru 1
Bitola 1
Boardman 1
Cislago 1
Dalmine 1
Darmstadt 1
Dearborn 1
Goyang-si 1
Guangzhou 1
Lake Forest 1
Maharagama 1
Nador 1
Piscataway 1
Rome 1
San Jose 1
Seattle 1
Seoul 1
Tel Aviv 1
Trujillo 1
Tunis 1
Vibo Valentia 1
Totale 193
Nome #
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells, file dfd1c04b-e232-0799-e053-6605fe0a8ddb 30
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment, file dfd1c04c-1719-0799-e053-6605fe0a8ddb 22
Pancreatic neuroendocrine tumors: Nosography, management and treatment, file dfd1c04a-f5b5-0799-e053-6605fe0a8ddb 21
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial, file dfd1c04b-f98c-0799-e053-6605fe0a8ddb 16
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis, file dfd1c04a-ffc4-0799-e053-6605fe0a8ddb 13
Sequential treatment with pazopanib and everolimus in metastatic renal cell carcinoma, file dfd1c04b-e08f-0799-e053-6605fe0a8ddb 12
Plantar Kaposi Sarcoma Revealed by Antisynthetase Syndrome, file dfd1c04c-1965-0799-e053-6605fe0a8ddb 10
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): From clinical trials to clinical practice, file dfd1c04b-38ff-0799-e053-6605fe0a8ddb 9
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions, file dfd1c04c-6ce8-0799-e053-6605fe0a8ddb 9
Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study., file dfd1c04b-3750-0799-e053-6605fe0a8ddb 7
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival, file dfd1c04b-01be-0799-e053-6605fe0a8ddb 4
Radiofrequency-assisted liver resection with a comb-shaped bipolar device versus clamp-crushing. A clinical study., file dfd1c04a-50c4-0799-e053-6605fe0a8ddb 3
Pancreatic stump closure after pancreatoduodenectomy in elderly patients: a retrospective clinical study, file dfd1c04b-f8c3-0799-e053-6605fe0a8ddb 3
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer?, file dfd1c04c-7719-0799-e053-6605fe0a8ddb 3
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer, file dfd1c04c-7792-0799-e053-6605fe0a8ddb 3
Novel investigational drugs for gastric cancer, file dfd1c04a-4835-0799-e053-6605fe0a8ddb 2
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells, file dfd1c04a-5c12-0799-e053-6605fe0a8ddb 2
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors, file dfd1c04a-6036-0799-e053-6605fe0a8ddb 2
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines, file dfd1c04a-60a4-0799-e053-6605fe0a8ddb 2
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer, file dfd1c04a-610e-0799-e053-6605fe0a8ddb 2
Endoscopic intraoperative anastomotic testing may avoid early gastrointestinal anastomotic complications. A prospective study, file dfd1c04a-69d8-0799-e053-6605fe0a8ddb 2
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors., file dfd1c04a-7045-0799-e053-6605fe0a8ddb 2
Emerging VEGF-receptor inhibitors for colorectal cancer., file dfd1c04a-70ff-0799-e053-6605fe0a8ddb 2
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience, file dfd1c04c-6d62-0799-e053-6605fe0a8ddb 2
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery., file dfd1c04c-6e86-0799-e053-6605fe0a8ddb 2
Efficacy and safety profile of amifostine in the preoperative combined therapy of esophageal cancer patients, file dfd1c04c-6eab-0799-e053-6605fe0a8ddb 2
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX., file dfd1c04c-7621-0799-e053-6605fe0a8ddb 2
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy., file dfd1c04c-76c3-0799-e053-6605fe0a8ddb 2
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer, file dfd1c04c-76d7-0799-e053-6605fe0a8ddb 2
Perspectives in adjuvant therapy of gastric cancer., file dfd1c04c-78ad-0799-e053-6605fe0a8ddb 2
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target., file dfd1c04c-78af-0799-e053-6605fe0a8ddb 2
ONCOLOGIA MEDICA, file dfd1c04c-79e3-0799-e053-6605fe0a8ddb 2
Early triple negative breast cancer: Conventional treatment and emerging therapeutic landscapes, file dfd1c04d-1ed7-0799-e053-6605fe0a8ddb 2
Testicular/paratesticular mesothelial tumours: Uncommon histopathologic entities in a very complex anatomical site, file 7a502c70-3106-40f0-acf1-d5c351e81d4c 1
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients, file dfd1c04a-234f-0799-e053-6605fe0a8ddb 1
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients., file dfd1c04a-2637-0799-e053-6605fe0a8ddb 1
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis, file dfd1c04a-4022-0799-e053-6605fe0a8ddb 1
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group, file dfd1c04a-46d4-0799-e053-6605fe0a8ddb 1
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study, file dfd1c04a-47df-0799-e053-6605fe0a8ddb 1
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study, file dfd1c04a-4a62-0799-e053-6605fe0a8ddb 1
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study., file dfd1c04a-5122-0799-e053-6605fe0a8ddb 1
Treatment of gastric cancer., file dfd1c04a-5557-0799-e053-6605fe0a8ddb 1
Prolonged corrected QT dispersion: early sign of doxorubicin cardiotoxicity?, file dfd1c04a-585f-0799-e053-6605fe0a8ddb 1
Ventricular repolarization time indexes following anthracycline treatment, file dfd1c04a-5a58-0799-e053-6605fe0a8ddb 1
Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: A phase II study, file dfd1c04a-5e31-0799-e053-6605fe0a8ddb 1
Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer., file dfd1c04a-61a4-0799-e053-6605fe0a8ddb 1
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases, file dfd1c04a-6d08-0799-e053-6605fe0a8ddb 1
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials., file dfd1c04a-6e6c-0799-e053-6605fe0a8ddb 1
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer., file dfd1c04a-6e6d-0799-e053-6605fe0a8ddb 1
Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer., file dfd1c04a-6fb6-0799-e053-6605fe0a8ddb 1
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis, file dfd1c04b-180c-0799-e053-6605fe0a8ddb 1
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research., file dfd1c04b-37ce-0799-e053-6605fe0a8ddb 1
Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial, file dfd1c04b-e4cc-0799-e053-6605fe0a8ddb 1
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study, file dfd1c04b-f6c3-0799-e053-6605fe0a8ddb 1
Efficacy of a triplet and doublet-based chemotherapy as first-line therapy in patients with HER2-negative metastatic gastric cancer: a retrospective analysis from the clinical practice, file dfd1c04b-fad0-0799-e053-6605fe0a8ddb 1
Integrated therapy in localized gastric cancer: targeted and tailored approach., file dfd1c04c-6eeb-0799-e053-6605fe0a8ddb 1
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study), file dfd1c04c-6ef1-0799-e053-6605fe0a8ddb 1
Chemoradiotherapy as adjuvant treatment of gastric cancer, file dfd1c04c-6f01-0799-e053-6605fe0a8ddb 1
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology Group, file dfd1c04c-6f3c-0799-e053-6605fe0a8ddb 1
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies, file dfd1c04c-7177-0799-e053-6605fe0a8ddb 1
Preoperative chemo-radiotherapy for carcinoma of the esophagus, file dfd1c04c-71fd-0799-e053-6605fe0a8ddb 1
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery, file dfd1c04c-765c-0799-e053-6605fe0a8ddb 1
Preoperative treatment of locally advanced esophageal carcinoma, file dfd1c04c-778c-0799-e053-6605fe0a8ddb 1
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma, file dfd1c04c-77fd-0799-e053-6605fe0a8ddb 1
Effect of cetuximab in recurrent and refractory squamous cell carcinoma of the head and neck (SCCHN): a case report, file dfd1c04c-78c0-0799-e053-6605fe0a8ddb 1
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis, file dfd1c04c-790c-0799-e053-6605fe0a8ddb 1
Neo-adjuvant and adjuvant chemotherapy of gastric cancer, file dfd1c04c-79ae-0799-e053-6605fe0a8ddb 1
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass, file dfd1c04c-79b0-0799-e053-6605fe0a8ddb 1
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery, file dfd1c04c-79b2-0799-e053-6605fe0a8ddb 1
Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis, file dfd1c04c-79d8-0799-e053-6605fe0a8ddb 1
Carcinoma dell'esofago, file dfd1c04c-79e5-0799-e053-6605fe0a8ddb 1
Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy, file dfd1c04c-7b5f-0799-e053-6605fe0a8ddb 1
Management of Liver Oligometastatic Esophageal Cancer: Overview and Critical Analysis of the Different Loco-Regional Treatments., file dfd1c04c-e06f-0799-e053-6605fe0a8ddb 1
Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer, file dfd1c04c-e305-0799-e053-6605fe0a8ddb 1
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score., file dfd1c04c-e60c-0799-e053-6605fe0a8ddb 1
Nivolumab in heavily pretreated metastatic gastric cancer patients: Real-life data from a western population, file dfd1c04d-14a1-0799-e053-6605fe0a8ddb 1
Feasibility of next-generation sequencing in clinical practice: Results of a pilot study in the Department of Precision Medicine at the University of Campania ' Luigi Vanvitelli', file dfd1c04d-2d52-0799-e053-6605fe0a8ddb 1
A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?, file dfd1c04d-b02f-0799-e053-6605fe0a8ddb 1
Naples Prognostic Score Predicts Tumor Regression Grade in Resectable Gastric Cancer Treated with Preoperative Chemotherapy, file dfd1c04d-d6ef-0799-e053-6605fe0a8ddb 1
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types, file ea9a8746-b0b3-4836-aea5-05f5b09fda46 1
Totale 248
Categoria #
all - tutte 1.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 0 12 2
2019/202021 1 1 0 0 2 2 0 9 1 0 3 2
2020/202141 0 0 0 0 6 4 3 1 1 0 2 24
2021/20227 0 0 0 0 0 1 0 0 1 1 4 0
2022/2023121 1 47 3 3 5 16 4 1 35 0 5 1
2023/202417 0 0 2 3 2 3 2 1 2 0 2 0
Totale 248